On September 21, Jintai Lithium Industry’s Phase-Two 4000t/a lithium carbonate project undertaken by Sunresin started production. Up to now, Sunresin has completed an accumulated 7000t/a lithium carbonate for Jintai Lithium Industry.
Over 10,000 visitors from the biotech industry, academics, government organizations and investment attended this year’s EBC BioConference with the latest trends, insights, developments and solutions to face the current challenges and opportunities. As a leading technical solution provider in the downstream purification process, Sunresin participated at the event showcasing its latest cutting-edge products and solutions, especially in the areas of chromatography resins for purification for key applications such as monoclonal antibodies.
Sunresin is delighted to announce that a Memorandum of Understanding ("MoU") has been signed with Anson Resources Limited (ASX: ASN), an Australian-based exploration and development company for industrial minerals, on a long-term alliance for the Paradox lithium project in Utah. According to the MoU, Sunresin will provide equipment, consumables, innovations and technical support services to Anson for the development, design, construction, operation and optimization of Sunresin’s proprietary Direct Lithium Extraction (DLE) technology for the production of battery-grade lithium carbonate at the Paradox project in Utah, USA.